Johnson & Johnson seeks to bar evidence of lost docs from pelvic mesh bellwether

Johnson & Johnson seeks to bar evidence of lost docs from pelvic mesh bellwether

Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon is facing sanction after a magistrate judge in West Virginia found that the medical device company lost or destroyed evidence in the multi-district litigation filed over its pelvic mesh products, wants to prevent a plaintiff from telling a jury about the snafu.

Plaintiffs in the case last year asked the U.S. District Court for Southern West Virginia to impose "severe sanctions" for Ethicon’s alleged mishandling and destruction of 10s of thousands of documents. Johnson & Johnson, C.R. Bard (NYSE:BCR), Boston Scientific (NYSE:BSX), Endo Health Solutions (NSDQ:ENDP), Cook Medical and Coloplast (CPH:COLO B) are facing thousands of product liability and personal injury lawsuits over their respective pelvic mesh devices used to treat female urinary incontinence. Cases against the companies have been consolidated into multi-district litigation under Judge Joseph Goodwin.

The plaintiffs in the Ethicon case wanted the court to declare a default judgment in their favor in some of the bellwether cases in the Ethicon MDL. They also asked that the court prevent the defendants from using the "learned intermediary" defense, in which a manufacturer argues that the duty of care is fulfilled when all necessary information is imparted to a "learned intermediary" who then interacts with the consumer. And they wanted the statute of limitations defense off the table for all of the Ethicon MDL cases, according to the documents.

Last week Magistrate Judge Cheryl Eifert found that, although Ethicon did destroy or lose "documents that should have been preserved in anticipation of this litigation," "Ethicon’s loss of evidence was negligent, not willful or deliberate, and plaintiffs have failed to establish a resulting prejudice sufficient to support the severe sanctions of default judgment, striking of defenses, and the offering of an adverse instruction in every case," according to court documents.

That ruling prompted Ethicon to ask Judge Joseph Goodwin to bar plaintiff Carolyn Lewis from telling the jury in her bellwether lawsuit about the lost or destroyed documents, according to the documents.

"Although Judge Eifert also suggested that evidence regarding Ethicon’s inadvertent loss of documents may be permitted at trial where there is evidence that documents relevant to a specific plaintiff’s claims were lost, this is not such a case. Ms. Lewis is proceeding solely on a theory of design defect, and Judge Eifert’s ruling makes clear that Ethicon produced relevant documents on design issues from central files," Ethicon argued, according to the documents. "Moreover, even if Ms. Lewis were alleging claims based on failure to warn, Ethicon has produced responsive documents from the files of the sales representative who covered the territory that included Ms. Lewis’ physician. This case should be tried on the merits of Ms. Lewis’ claims – not plaintiffs’ irrelevant spoliation allegations. And plaintiffs should not be allowed to circumvent Judge Eifert’s denial of an adverse inference by introducing irrelevant, highly prejudicial evidence about Ethicon’s loss of documents at trial."

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply